Stable conditions such as neuromuscular disease or stable coronary artery disease may be differentially associated with hs-cTnT and hs-cTnI whereby elevated hs-cTnT and hs-cTnI were presumed to represent distinct pathophysiologic processes [5–10]. This evidence concerns the gene TNNI3 and neuromuscular disease.